Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.

导出 OA

翻译打印收藏纠错

作者： María Del Mar,Noblejas-López ^[1] ; Mariona,Baliu-Piqué ^[2] ; Cristina,Nieto-Jiménez ^[3] ; Francisco J,Cimas ^[3] ; Esther C,Morafraile ^[1] ; Atanasio,Pandiella ^[2] ; Ángel L,Corbi ^[3] ; Balázs,Győrffy ^[4] ; Alberto,Ocaña ^[5]

作者单位： Translational Oncology Laboratory, Translational Research Unit, Albacete University Hospital, 02008 Albacete, Spain. ^[1] Centro Regional de Investigaciones Biomédicas, Castilla-La Mancha University (CRIB-UCLM), 02008 Albacete, Spain. ^[2] Experimental Therapeutics Unit, Medical Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria (IdISSC) and CIBERONC, 28029 Madrid, Spain. ^[3] Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), 37007 Salamanca, Spain. ^[4] Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain. ^[5] CIBERONC, 37007 Salamanca, Spain. ^[6] Consejo Superior de Investigaciones Científicas (CSIC), 37007 Salamanca, Spain. ^[7] Centro de Investigaciones Biológicas (CIB), Departamento de Biología Celular, Consejo Superior de Investigaciones Científicas (CSIC), 28029 Madrid, Spain. ^[8] Department of Bioinformatics, Semmelweis University, H-1094 Budapest, Hungary. ^[9] 2nd Department of Pediatrics, Semmelweis University, H-1094 Budapest, Hungary. ^[10] TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, H-1117 Budapest, Hungary. ^[11]

关键词 CD47 breast cancer immune activation immunotherapy pro-tumoral macrophages